This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Oct;147(10):1211-3.

doi: 10.1001/archdermatol.2011.234.

Lentigo maligna: one size does not fit all

Glen M Bowen, Anneli R Bowen, Scott R Florell

PMID: 22006139
DOI: 10.1001/archdermatol.2011.234

Editorial

Lentigo maligna: one size does not fit all

Glen M Bowen et al. Arch Dermatol. 2011 Oct.

. 2011 Oct;147(10):1211-3.

doi: 10.1001/archdermatol.2011.234.

Authors

Glen M Bowen, Anneli R Bowen, Scott R Florell

PMID: 22006139
DOI: 10.1001/archdermatol.2011.234

No abstract available

PubMed Disclaimer

Similar articles

[Imiquimod in the treatment of lentigo maligna].
Nagore E, Botella-Estrada R. Nagore E, et al. Actas Dermosifiliogr. 2011 Oct;102(8):559-62. doi: 10.1016/j.ad.2011.03.003. Epub 2011 May 4. Actas Dermosifiliogr. 2011. PMID: 21536245 Review. Spanish. No abstract available.
Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology.
Arlette JP, Trotter MJ, Trotter T, Temple CL. Arlette JP, et al. J Surg Oncol. 2004 Jul 1;86(4):179-86. doi: 10.1002/jso.20081. J Surg Oncol. 2004. PMID: 15221924 Review.
Lentigo maligna of the cheek: discussion of surgical treatment options.
Ratner D. Ratner D. Skinmed. 2002 Nov-Dec;1(2):144-6. Skinmed. 2002. PMID: 14673342 No abstract available.
Nine per cent of biopsy-proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery.
Zoutendijk J, Tio D, Koljenovic S, van den Bos RR. Zoutendijk J, et al. Br J Dermatol. 2019 Aug;181(2):383-384. doi: 10.1111/bjd.17714. Epub 2019 Apr 15. Br J Dermatol. 2019. PMID: 30716164 Free PMC article. No abstract available.
Treatment of lentigo maligna.
Carucci JA. Carucci JA. Cutis. 2001 May;67(5):389-92. Cutis. 2001. PMID: 11381854

See all similar articles

Cited by

Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models.
Michel D, Mohammed-Saeid W, Getson H, Roy C, Poorghorban M, Chitanda JM, Verrall R, Badea I. Michel D, et al. Int J Nanomedicine. 2016 Dec 12;11:6703-6712. doi: 10.2147/IJN.S121156. eCollection 2016. Int J Nanomedicine. 2016. PMID: 28003746 Free PMC article.
Dermal vasculature and melanocytic proliferation index in photodamaged skin in the assessment of lateral margins of lentigo maligna and lentigo maligna melanoma.
Stelini RF, Neves NM, de Souza SPM, Florence MEB, Sánchez-Romero C, Soares AB, de Almeida OP, Cintra ML. Stelini RF, et al. Int J Clin Exp Pathol. 2018 Sep 1;11(9):4703-4710. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31949871 Free PMC article.
Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision.
Donigan JM, Hyde MA, Goldgar DE, Hadley ML, Bowling M, Bowen GM. Donigan JM, et al. JAMA Dermatol. 2018 Aug 1;154(8):885-889. doi: 10.1001/jamadermatol.2018.0530. JAMA Dermatol. 2018. PMID: 29847610 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information